Novel <i>myo</i> -inositol to butyrate fermentation pathway in the prevalent human gut species <i>Dysosmobacter welbionis,</i> a bacterium associated with improved metabolic and liver health

<i>D. welbionis</i> possesses a unique, conserved route to convert dietary <i>myo</i>-inositol into butyrate, distinguishing it from other commensals and supporting its potential as a next-generation probiotic for metabolic and liver health.

Authors

Institutions

Publication Details

Journal
Gut
Published
2026-01-07
DOI
https://doi.org/10.1136/gutjnl-2025-336617
Citations
1
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
31.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel myo -inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health

Antonio Dario Troise, Thi Phuong Nam Bui, Sjef Boeren, Samuel Bellais et al.
1 citations
Gut
Liver Disease Diagnosis and Treatment
31.52
article

Novel myo -inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health

Antonio Dario Troise, Thi Phuong Nam Bui, Sjef Boeren, Samuel Bellais, Nathalie M. Delzenne, Massimo Federici, Rémy Burcelin, Matthias Van Hul, Anthony Puel, Giulio G. Muccioli, Tiphaine Le Roy, Lesley Hoyles, Giselle C. Wong, Mélanie Nehlich, Patrice D. Cani, Camille Petitfils, Thomas Clavel, Andrea Scaloni, Manyi Jia, José Manuel Fernandez-Real, Dumas Marc-Emmanuel, Bouthaina Ben Abdallah, Chi-Hsien Lee, Thomas Leicht, Ching Jian, Willem M De Vos
article en
1 citations

Abstract

<i>D. welbionis</i> possesses a unique, conserved route to convert dietary <i>myo</i>-inositol into butyrate, distinguishing it from other commensals and supporting its potential as a next-generation probiotic for metabolic and liver health.

Gut
University of Rome Tor Vergata (IT), Centre National de la Recherche Scientifique (FR), University of Helsinki (FI), Inserm (FR), Universitat de Girona (ES), Instituto de Salud Carlos III (ES), Istituto Neurologico Mediterraneo (IT), Sorbonne Université (FR), Nutrition et obésité : approches systémiques (FR), Istituto per il Sistema Produzione Animale in Ambiente Mediterraneo (IT), Centro de Investigación Biomédica en Red (ES), Hôpital Rangueil (FR), BIOASTER (FR), Walloon Excellence in Lifesciences and Biotechnology (BE), Amsterdam University Medical Centers (NL), Hospital Universitari de Girona Doctor Josep Trueta (ES), National Research Council (IT), European Genomic Institute for Diabetes (FR), Imperial College London (GB), Nottingham Trent University (GB), University of Amsterdam (NL), RWTH Aachen University (DE), Wageningen University & Research (NL), UCLouvain (BE)
Openalex Percentile: Top 2%
Liver Disease Diagnosis and Treatment
31.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.